annual EBITDA:
-$561.51M-$385.84M(-219.64%)Summary
- As of today (May 29, 2025), ARWR annual EBITDA is -$561.51 million, with the most recent change of -$385.84 million (-219.64%) on September 30, 2024.
- During the last 3 years, ARWR annual EBITDA has fallen by -$428.93 million (-323.53%).
- ARWR annual EBITDA is now -955.57% below its all-time high of $65.63 million, reached on September 30, 2019.
Performance
ARWR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$397.34M+$545.57M(+368.05%)Summary
- As of today (May 29, 2025), ARWR quarterly EBITDA is $397.34 million, with the most recent change of +$545.57 million (+368.05%) on March 31, 2025.
- Over the past year, ARWR quarterly EBITDA has increased by +$512.57 million (+444.83%).
- ARWR quarterly EBITDA is now at all-time high.
Performance
ARWR quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$68.12M+$512.57M(+88.27%)Summary
- As of today (May 29, 2025), ARWR TTM EBITDA is -$68.12 million, with the most recent change of +$512.57 million (+88.27%) on March 31, 2025.
- Over the past year, ARWR TTM EBITDA has increased by +$370.98 million (+84.49%).
- ARWR TTM EBITDA is now -203.80% below its all-time high of $65.63 million, reached on September 30, 2019.
Performance
ARWR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ARWR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -219.6% | +444.8% | +84.5% |
| 3 y3 years | -323.5% | +746.1% | +30.4% |
| 5 y5 years | -955.6% | +2004.1% | -1262.7% |
ARWR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -323.5% | at low | at high | +342.1% | at high | +88.3% |
| 5 y | 5-year | -955.6% | at low | at high | +342.1% | -1262.7% | +88.3% |
| alltime | all time | -955.6% | at low | at high | +342.1% | -203.8% | +88.3% |
ARWR EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $397.34M(-368.0%) | -$68.12M(-88.3%) |
| Dec 2024 | - | -$148.23M(-3.2%) | -$580.69M(+3.4%) |
| Sep 2024 | -$561.51M(+219.6%) | -$153.13M(-6.7%) | -$561.51M(+10.5%) |
| Jun 2024 | - | -$164.10M(+42.4%) | -$508.26M(+15.7%) |
| Mar 2024 | - | -$115.23M(-10.7%) | -$439.10M(+63.6%) |
| Dec 2023 | - | -$129.06M(+29.2%) | -$268.48M(+52.8%) |
| Sep 2023 | -$175.67M(+8.2%) | -$99.87M(+5.2%) | -$175.67M(+13.1%) |
| Jun 2023 | - | -$94.95M(-271.4%) | -$155.30M(+19.6%) |
| Mar 2023 | - | $55.40M(-252.8%) | -$129.80M(-6.1%) |
| Dec 2022 | - | -$36.26M(-54.4%) | -$138.25M(-15.1%) |
| Sep 2022 | -$162.29M(+22.4%) | -$79.50M(+14.5%) | -$162.74M(+18.4%) |
| Jun 2022 | - | -$69.45M(-247.9%) | -$137.43M(+40.5%) |
| Mar 2022 | - | $46.96M(-177.3%) | -$97.85M(-42.8%) |
| Dec 2021 | - | -$60.75M(+12.1%) | -$171.12M(+29.1%) |
| Sep 2021 | -$132.58M(+52.0%) | -$54.19M(+81.4%) | -$132.58M(+4.6%) |
| Jun 2021 | - | -$29.87M(+13.5%) | -$126.74M(+13.9%) |
| Mar 2021 | - | -$26.31M(+18.5%) | -$111.28M(+5.1%) |
| Dec 2020 | - | -$22.21M(-54.1%) | -$105.83M(+21.3%) |
| Sep 2020 | -$87.22M(-232.9%) | -$48.34M(+235.5%) | -$87.22M(+209.8%) |
| Jun 2020 | - | -$14.41M(-30.9%) | -$28.15M(-580.5%) |
| Mar 2020 | - | -$20.87M(+480.8%) | $5.86M(-88.3%) |
| Dec 2019 | - | -$3.59M(-133.5%) | $49.91M(-23.9%) |
| Sep 2019 | $65.63M(-228.1%) | $10.72M(-45.3%) | $65.63M(+45.9%) |
| Jun 2019 | - | $19.60M(-15.5%) | $44.97M(+323.2%) |
| Mar 2019 | - | $23.19M(+91.3%) | $10.63M(-140.2%) |
| Dec 2018 | - | $12.12M(-222.0%) | -$26.44M(-48.4%) |
| Sep 2018 | -$51.24M(+58.6%) | -$9.94M(-32.6%) | -$51.24M(+1.7%) |
| Jun 2018 | - | -$14.74M(+6.2%) | -$50.39M(+25.4%) |
| Mar 2018 | - | -$13.88M(+9.5%) | -$40.20M(+28.6%) |
| Dec 2017 | - | -$12.67M(+39.3%) | -$31.26M(-3.2%) |
| Sep 2017 | -$32.31M(-57.7%) | -$9.10M(+99.8%) | -$32.31M(-23.3%) |
| Jun 2017 | - | -$4.55M(-7.9%) | -$42.11M(-24.9%) |
| Mar 2017 | - | -$4.94M(-64.0%) | -$56.08M(-21.7%) |
| Dec 2016 | - | -$13.72M(-27.4%) | -$71.60M(-6.3%) |
| Sep 2016 | -$76.43M(-18.4%) | -$18.90M(+2.0%) | -$76.43M(-6.7%) |
| Jun 2016 | - | -$18.52M(-9.5%) | -$81.91M(+4.2%) |
| Mar 2016 | - | -$20.46M(+10.3%) | -$78.63M(-10.0%) |
| Dec 2015 | - | -$18.55M(-23.9%) | -$87.36M(-6.7%) |
| Sep 2015 | -$93.64M(+88.2%) | -$24.37M(+59.8%) | -$93.64M(+5.0%) |
| Jun 2015 | - | -$15.25M(-47.7%) | -$89.17M(+3.3%) |
| Mar 2015 | - | -$29.18M(+17.6%) | -$86.34M(+27.0%) |
| Dec 2014 | - | -$24.83M(+24.7%) | -$67.98M(+36.6%) |
| Sep 2014 | -$49.76M(+131.1%) | -$19.91M(+60.3%) | -$49.76M(+32.9%) |
| Jun 2014 | - | -$12.42M(+14.9%) | -$37.45M(+26.3%) |
| Mar 2014 | - | -$10.82M(+63.7%) | -$29.65M(+24.7%) |
| Dec 2013 | - | -$6.61M(-13.1%) | -$23.78M(+10.4%) |
| Sep 2013 | -$21.53M(+11.3%) | -$7.60M(+64.2%) | -$21.53M(+14.1%) |
| Jun 2013 | - | -$4.63M(-6.4%) | -$18.86M(-8.5%) |
| Mar 2013 | - | -$4.94M(+13.3%) | -$20.61M(+2.5%) |
| Dec 2012 | - | -$4.36M(-11.6%) | -$20.12M(+4.0%) |
| Sep 2012 | -$19.34M | -$4.93M(-22.7%) | -$19.34M(+12.1%) |
| Jun 2012 | - | -$6.38M(+43.5%) | -$17.26M(+37.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$4.44M(+24.0%) | -$12.58M(+27.3%) |
| Dec 2011 | - | -$3.58M(+25.9%) | -$9.88M(+3.3%) |
| Sep 2011 | -$9.56M(+72.1%) | -$2.85M(+67.2%) | -$9.56M(+13.4%) |
| Jun 2011 | - | -$1.70M(-2.3%) | -$8.43M(+4.7%) |
| Mar 2011 | - | -$1.74M(-46.6%) | -$8.05M(+120.5%) |
| Dec 2010 | - | -$3.27M(+90.3%) | -$3.65M(+54.1%) |
| Sep 2010 | -$5.56M(-70.1%) | -$1.72M(+29.8%) | -$2.37M(-39.8%) |
| Jun 2010 | - | -$1.32M(-149.8%) | -$3.94M(-15.4%) |
| Mar 2010 | - | $2.66M(-233.7%) | -$4.65M(-62.1%) |
| Dec 2009 | - | -$1.99M(-39.5%) | -$12.26M(-34.0%) |
| Sep 2009 | -$18.57M(-45.2%) | -$3.28M(+61.0%) | -$18.57M(-30.1%) |
| Jun 2009 | - | -$2.04M(-58.8%) | -$26.56M(-22.2%) |
| Mar 2009 | - | -$4.95M(-40.2%) | -$34.15M(-5.1%) |
| Dec 2008 | - | -$8.29M(-26.5%) | -$35.97M(+4.9%) |
| Sep 2008 | -$33.87M(-8.3%) | -$11.28M(+17.1%) | -$34.28M(-0.2%) |
| Jun 2008 | - | -$9.63M(+42.1%) | -$34.36M(-9.3%) |
| Mar 2008 | - | -$6.78M(+2.7%) | -$37.88M(-3.6%) |
| Dec 2007 | - | -$6.60M(-41.9%) | -$39.30M(+6.4%) |
| Sep 2007 | -$36.95M(+88.5%) | -$11.36M(-13.6%) | -$36.95M(+18.4%) |
| Jun 2007 | - | -$13.14M(+60.3%) | -$31.19M(+39.6%) |
| Mar 2007 | - | -$8.20M(+93.3%) | -$22.34M(+12.3%) |
| Dec 2006 | - | -$4.24M(-24.2%) | -$19.89M(+1.8%) |
| Sep 2006 | -$19.60M(+119.0%) | -$5.60M(+30.5%) | -$19.54M(+13.9%) |
| Jun 2006 | - | -$4.29M(-25.4%) | -$17.15M(+10.6%) |
| Mar 2006 | - | -$5.76M(+48.2%) | -$15.51M(+37.6%) |
| Dec 2005 | - | -$3.88M(+20.8%) | -$11.27M(+25.8%) |
| Sep 2005 | -$8.95M(+242.1%) | -$3.21M(+21.1%) | -$8.96M(+26.3%) |
| Jun 2005 | - | -$2.65M(+74.6%) | -$7.09M(+40.9%) |
| Mar 2005 | - | -$1.52M(-3.2%) | -$5.03M(+24.5%) |
| Dec 2004 | - | -$1.57M(+16.5%) | -$4.04M(+54.6%) |
| Sep 2004 | -$2.62M(+2674.2%) | -$1.35M(+126.7%) | -$2.62M(+103.5%) |
| Jun 2004 | - | -$594.30K(+11.9%) | -$1.29M(+82.5%) |
| Mar 2004 | - | -$531.10K(+273.2%) | -$704.40K(+250.3%) |
| Dec 2003 | - | -$142.30K(+708.5%) | -$201.10K(+124.9%) |
| Sep 2003 | -$94.30K(-93.3%) | -$17.60K(+31.3%) | -$89.40K(-93.6%) |
| Jun 2003 | - | -$13.40K(-51.8%) | -$1.39M(-2.2%) |
| Mar 2003 | - | -$27.80K(-9.2%) | -$1.42M(+0.4%) |
| Dec 2002 | - | -$30.60K(-97.7%) | -$1.41M(+0.3%) |
| Sep 2002 | -$1.41M(+1270.1%) | -$1.32M(+2895.9%) | -$1.41M(+1054.4%) |
| Jun 2002 | - | -$43.90K(+96.0%) | -$121.90K(+30.4%) |
| Mar 2002 | - | -$22.40K(-12.8%) | -$93.50K(-1.5%) |
| Dec 2001 | - | -$25.70K(-14.0%) | -$94.90K(-7.1%) |
| Sep 2001 | -$102.70K(+1.1%) | -$29.90K(+92.9%) | -$102.20K(+3.8%) |
| Jun 2001 | - | -$15.50K(-34.9%) | -$98.50K(-5.4%) |
| Mar 2001 | - | -$23.80K(-27.9%) | -$104.10K(+0.4%) |
| Dec 2000 | - | -$33.00K(+26.0%) | -$103.70K(+2.1%) |
| Sep 2000 | -$101.60K(+111.2%) | -$26.20K(+24.2%) | -$101.60K(+34.7%) |
| Jun 2000 | - | -$21.10K(-9.8%) | -$75.40K(+38.9%) |
| Mar 2000 | - | -$23.40K(-24.3%) | -$54.30K(+75.7%) |
| Dec 1999 | - | -$30.90K | -$30.90K |
| Sep 1999 | -$48.10K(+218.5%) | - | - |
| Sep 1998 | -$15.10K(-72.4%) | - | - |
| Sep 1997 | -$54.80K | - | - |
FAQ
- What is Arrowhead Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual EBITDA year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Arrowhead Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals TTM EBITDA year-on-year change?
What is Arrowhead Pharmaceuticals annual EBITDA?
The current annual EBITDA of ARWR is -$561.51M
What is the all time high annual EBITDA for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual EBITDA is $65.63M
What is Arrowhead Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, ARWR annual EBITDA has changed by -$385.84M (-219.64%)
What is Arrowhead Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of ARWR is $397.34M
What is the all time high quarterly EBITDA for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly EBITDA is $397.34M
What is Arrowhead Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, ARWR quarterly EBITDA has changed by +$512.57M (+444.83%)
What is Arrowhead Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of ARWR is -$68.12M
What is the all time high TTM EBITDA for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high TTM EBITDA is $65.63M
What is Arrowhead Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, ARWR TTM EBITDA has changed by +$370.98M (+84.49%)